Moderate coding expectations
QA engineers face lighter coding rounds focused on test automation scripts, API testing, and basic algorithms. Emphasis on clean, maintainable test code.
0 roles from funded startups and hidden sources. Posted
minutes ago. Updated every 60 seconds
Focus areas that matter most for testing positions. Explore key insights and preparation tips to help you excel in your interview process.
QA engineers face lighter coding rounds focused on test automation scripts, API testing, and basic algorithms. Emphasis on clean, maintainable test code.
Design comprehensive testing strategies, CI/CD pipelines, and quality assurance processes for large-scale systems.
Test Strategy
End-to-end testing frameworks
CI/CD Design
Automated testing pipelines
Quality Gates
Release validation systems
Different companies emphasize various aspects of quality assurance based on their product and scale.
Meta
Mobile testing and performance validation
Stripe
API testing and payment system reliability
Compare cost-of-living buying power and how crowded the market is versus other major tech cities—so you can focus your search where the odds fit your goals.
Baltimore offers approximately 70% lower housing costs compared to San Francisco, with median home prices around $200K versus $1.2M+ in the Bay Area. Your QA Engineer salary stretches significantly further while maintaining access to major East Coast tech corridors.
Baltimore's emerging tech scene means less saturated QA talent pools compared to traditional hubs. Growing cybersecurity and fintech sectors create abundant opportunities for quality assurance professionals.

New roles go live every minute and the earliest applicants win. Get the freshest, verified listings delivered straight to your inbox before most job seekers ever see them.
👉 Get free daily job postsPearl Diagnostics is a Baltimore-based biotech spun out of Johns Hopkins University in 2014 that builds non-invasive urine-based diagnostic tests for lung infections. Its flagship MycoMEIA Aspergillus urine assay, which received FDA 510(k) clearance in August 2025 and CE approval for the EU, replaces invasive bronchoalveolar lavage procedures used to detect aspergillosis in transplant recipients, cancer patients, and immunocompromised individuals. The company is extending the same antigen-detection platform to other fungal and bacterial pathogens, including a Pseudomonas assay for cystic fibrosis patients.
Raised
$11.2M
Series A · 2026
Key contacts
-
Leadership & hiring contacts indexed
HQ market
Baltimore, Maryland
United States